Skip to content

Exercise Intervention Obesity Improvement Trial 2023

Exploratory study of individual differences in the weight loss effect of exercise intervention on obese people [Trial No. g2023003] - Exploratory study of individual differences in the weight loss effect of exercise intervention on obese people [Trial No. g2023003]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051802
Enrollment
60
Registered
2023-08-10
Start date
2023-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Exercise guidance for weight loss and visceral fat reduction will be provided once every two weeks for two months.

Sponsors

Macromill,Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Obese or lightly obese (Body Mass Index [BMI] >=25, If insufficient number of subjects, BMI >=23). 2.Person who has a diet intention. 3.Person who has a smartphone and can record meals and write a life diary using the app. 4.Person who agree to use the exercise and diet management app "Asken".

Exclusion criteria

Exclusion criteria: 1. Person who has suffer from chronic diseases currently (diabetes, hypertension, hyperlipidemia, gout, kidney disease, rheumatism, respiratory disease, etc.) and are taking medication. 2. Person who has difficulty participating in research due to liver, kidney, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, or other diseases. 3. Person who with alcoholic drinkers. (alcohol equivalent 60g / day or more) : (Beer: 3 medium bottles (1.5L), Sake: 3 go (540ml), Whiskey: 3 double glasses (180ml), Shochu: 1.8go (330ml) or more) 4. Person who has a history of gastrointestinal resection (excluding cecal resection). 5. Person who has collected 200 mL of blood (donated blood, etc.) within 1 month or 400 mL or more within 3 months of the start of this study. 6. Person who has skin diseases (atopic dermatitis, acne vulgaris, psoriasis, etc.) on face. 7. Person who use medical external medicine on the face. 8. Person who has excessive sunburn on the face. 9. Person who has skin diseases, metal allergies, pacemakers, etc. in their bodies. 10. Person who plan to participate in other clinical trials during the trial participation period. 11. Person who are not day shifts such as night shifts and rotation shifts. 12. Person who has felt sick at the time of blood collection, or person who has difficulty in collecting blood because the blood vessels in the arm are difficult to see. 13. Person who has a history of drug dependence, alcohol dependence, or current medical history. 14. Person who has plan to travel or travel for more than 2 weeks during the test period. 15. Person with low physical fitness who cannot exercise (such as walking fast for 20 minutes or more), or person who have orthopedic area disease or orthopedic chronic disease. 16. Person who has deemed inappropriate to participate in this study by the principle investigator.

Design outcomes

Primary

MeasureTime frame
Analysis of the relationship between weight loss / visceral fat loss before and after the intervention and other measurement items (physical test, blood test, etc.)

Secondary

MeasureTime frame
Comprehensive relevance analysis of all measurement items.

Countries

Japan

Contacts

Public ContactTakahiro Hasumura

Kao Corporation Biological Science Research Lab.

hasumura.takahiro@kao.com+81-3-5630-7268

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026